Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Jenburkt Pharmaceuticals had annual revenue of 1.52B INR with 6.85% growth. Jenburkt Pharmaceuticals had revenue of 410.47M in the quarter ending March 31, 2025, with 5.68% growth.

• Revenue: 1.52B
• Revenue Growth: +6.85%
• P/S Ratio: 3.79
• Revenue / Employee: 1.95M
• Employees: 779
• Market Cap: 5.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.52B	97.25M	6.85%
Mar 31, 2024	1.42B	52.17M	3.82%
Mar 31, 2023	1.37B	127.69M	10.30%
Mar 31, 2022	1.24B	146.86M	13.44%
Mar 31, 2021	1.09B	-95.97M	-8.07%